Answers are grounded in this paper and cite their sources.
Results from this real-world clinical registry indicate that a majority of CD subjects with moderate/severe neck pain experience significant relief following onabotulinumtoxinA treatment.
No takes yet. Share an insight, caveat, or question.
Charles et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: